Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.

导出 LinkOut

翻译打印收藏纠错

第一作者： Daniel,Šaňák

第一单位： Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic. Electronic address: daniel.sanak@centrum.cz.

作者： Daniel,Šaňák ^[1] ; Stanislava,Jakubíček ^[2] ; David,Černík ^[3] ; Roman,Herzig ^[4] ; Zdeněk,Kunáš ^[5] ; Robert,Mikulík ^[6] ; Svatopluk,Ostrý ^[5] ; Michal,Reif ^[6] ; Vladimír,Rohan ^[7] ; Aleš,Tomek ^[8] ; Tomáš,Veverka ^[9]

作者单位： Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic. Electronic address: daniel.sanak@centrum.cz. ^[1] Department of Neurology, Masaryk University Faculty of Medicine and St. Anne's University Hospital, Brno, Czech Republic. ^[2] Department of Neurology, Comprehensive Stroke Center, Masaryk Hospital Ústí nad Labem, KZ A.S., Ústí nad Labem, Czech Republic. ^[3] Department of Neurology, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic. ^[4] Department of Neurology, Comprehensive Stroke Center, Hospital České Budějovice, České Budějovice, Czech Republic. ^[5] International Clinical Research Center and Department of Neurology, St. Anne's University Hospital, Brno, Czech Republic. ^[6] Department of Neurology, Faculty of Medicine in Plzen, Comprehensive Stroke Center, Charles University in Prague and Faculty Hospital Plzen, Pilsen, Czech Republic. ^[7] Department of Neurology, Comprehensive Stroke Center, Charles University Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic. ^[8] Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic. ^[9]

关键词 Acute ischemic stroke anticoagulation antidote dabigatran intravenous thrombolysis reversal